Skip to content
AnalystLens

Kimberly-Clark 8-K Report, Regulation FD Disclosure (Jul 25, 2025)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed July 25, 2025
Period End
July 25, 2025
Security
KMB
In the record · 2016–202610-K1110-Q328-K111

KMB filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 111 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Sep ’18Sep ’18
  2. Change in control8-K · Sep ’20Sep ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Deal closed8-K · Nov ’26Nov ’26

01—Abstract

Summary

Summary of the 8-K filed July 25, 2025. Cited figures are marked; the original filing is the authoritative source.

Kimberly-Clark Corporation furnished this Current Report to disclose supplemental historical financial information recast to reflect its International Family Care and Professional (IFP) business as discontinued operations.

This follows the June 5, 2025 announcement of a joint venture with Suzano S.A., in which Suzano and certain wholly-owned subsidiaries will acquire a 51% interest in the joint venture for a purchase price of approximately $1.7 billiona, subject to closing adjustments, while the Company retains a 49% equity interest. Closing is expected in mid-2026, subject to consultation requirements, customary closing conditions and required regulatory approvals. Because the IFP Transaction is a strategic shift with a major effect on operations, the IFP results are reported as discontinued operations effective in the second quarter of fiscal 2025 and are excluded from continuing operations and segment results for all periods presented.

Continuing operations are now organized into two geographic reportable segments, North America and International Personal Care, with Corporate and Other covering divested former IFP operations and unallocated costs. The filing states these recast changes have no impact on consolidated results previously reported in the Forms 10-Q or the 2024 Form 10-K. Recast figures show 2024 continuing-operations net sales of $16.81 billionb versus $17.15 billion in 2023, and income from continuing operations of $2.19 billion versus $1.46 billion.

Discontinued operations (IFP) contributed net sales of $3.25 billionc in 2024 and income of $386 million, versus $3.29 billion and $305 million in 2023. The supplemental information also presents adjusted non-GAAP measures, including 2024 adjusted diluted EPS of $6.16 versus $5.67 in 2023, and first-quarter 2025 adjusted EPS of $1.62 versus $1.71 in the first quarter of 2024.

02—Key points

Key Highlights

  1. Kimberly-Clark will form a joint venture with Suzano S.A. comprising substantially all of the former IFP segment; Suzano will acquire a 51% interest for approximately $1.7 billion, subject to closing adjustments, and the Company will keep 49%.
  2. Closing is expected in mid-2026, subject to consultation requirements, customary closing conditions and required regulatory approvals.
  3. IFP results are reported as discontinued operations effective Q2 2025, and continuing operations now report two geographic segments: North America and International Personal Care.
  4. Recast 2024 continuing-operations net sales were $16.81 billion (2023: $17.15 billion); 2024 operating profit was $2.70 billion (2023: $1.93 billion).
  5. Income from discontinued operations (IFP) was $386 million in 2024 and $305 million in 2023, net of income taxes.
  6. 2024 diluted EPS from continuing operations was $6.41 and adjusted EPS was $6.16, compared with $5.67 adjusted EPS in 2023.
  7. First-quarter 2025 net sales from continuing operations were $4.05 billion, with diluted EPS of $1.70 including $0.31 from discontinued operations.

03—Questions

Frequently Asked Questions

  1. What is the IFP Transaction and what will Kimberly-Clark retain?

    The IFP Transaction is a joint venture with Suzano S.A. comprising substantially all operations of the former International Family Care and Professional segment. Suzano and certain wholly-owned subsidiaries will acquire a 51% interest for approximately $1.7 billion, subject to closing adjustments, and Kimberly-Clark will retain a 49% equity interest.

  2. When is the IFP Transaction expected to close?

    The filing states closing is expected to take place in mid-2026, following satisfaction of consultation requirements and customary closing conditions, including obtaining required regulatory approvals.

  3. Why are IFP results presented as discontinued operations?

    Under ASC 205, the Company determined the IFP Transaction represents a strategic shift that will have a major effect on its operations and financial results. Effective in the second quarter of fiscal 2025, IFP results are excluded from continuing operations and segment results for all periods presented.

  4. How did continuing operations perform on a recast basis?

    For 2024, recast net sales from continuing operations were $16.81 billion, down from $17.15 billion in 2023, while operating profit rose to $2.70 billion from $1.93 billion. Income from continuing operations was $2.19 billion in 2024 versus $1.46 billion in 2023.

  5. Does this filing change previously reported consolidated results?

    No. The filing states the recast changes had no impact on consolidated financial results for any periods presented in the Company's Forms 10-Q for the respective interim periods or in the 2024 Form 10-K.

04—Continue

← View all 8-K filings